Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.
about
Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vesselsA Systemized Approach to Investigate Ca(2+) Synchronization in Clusters of Human Induced Pluripotent Stem-Cell Derived CardiomyocyteshiPSC Modeling of Inherited CardiomyopathiesDynamic link between histone H3 acetylation and an increase in the functional characteristics of human ESC/iPSC-derived cardiomyocytesGenome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging.Measuring the contractile forces of human induced pluripotent stem cell-derived cardiomyocytes with arrays of micropostsChemical genetics and its potential in cardiac stem cell therapy.Effects of miR-19b overexpression on proliferation, differentiation, apoptosis and Wnt/β-catenin signaling pathway in P19 cell model of cardiac differentiation in vitro.Nitric oxide-cyclic GMP signaling in stem cell differentiationThe potential of stem cells in the treatment of skeletal muscle injury and diseasePhenotyping patient-derived cells for translational studies in cardiovascular disease.Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias.Micropost arrays for measuring stem cell-derived cardiomyocyte contractility.Pluripotent Stem Cells and DNA Damage Response to Ionizing Radiations.Human Cord Blood-Derived CD133+/C-Kit+/Lin- Cells Have Bipotential Ability to Differentiate into Mesenchymal Stem Cells and Outgrowth Endothelial Cells.Human pluripotent stem cells for genetic disease modeling and drug screening.Optimizing dynamic interactions between a cardiac patch and inflammatory host cells.Engineered tissue grafts: opportunities and challenges in regenerative medicine.Human pluripotent stem cells for disease modelling and drug screening.Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models.Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration.Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair.Cardiac stem cell therapy: stemness or commitment?Prospective in vitro models of channelopathies and cardiomyopathiesCardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractilityApplication of high-throughput sequencing for studying genomic variations in congenital heart disease.Techniques for the induction of human pluripotent stem cell differentiation towards cardiomyocytes.Cardiac Regeneration: Lessons From Development.Somatic Cell Reprogramming into Cardiovascular Lineages.Continuous antagonism by Dkk1 counter activates canonical Wnt signaling and promotes cardiomyocyte differentiation of embryonic stem cells.Real-Time Force and Frequency Analysis of Engineered Human Heart Tissue Derived from Induced Pluripotent Stem Cells Using Magnetic Sensing.Cell memory-based therapy.Direct Reprogramming of Human Suspension Cells into Mesodermal Cell Lineages via Combined Magnetic Targeting and Photothermal Stimulation by Magnetic Graphene Oxide Complexes.Quantification of Etoposide Hypersensitivity: A Sensitive, Functional Method for Assessing Pluripotent Stem Cell Quality.Xenotransplanted embryonic kidney provides a niche for endogenous mesenchymal stem cell differentiation into erythropoietin-producing tissue.NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes.Cardiomyocyte differentiation from mouse embryonic stem cells using a simple and defined protocol.Myocardial Reprogramming Medicine: The Development, Application, and Challenge of Induced Pluripotent Stem Cells
P2860
Q24295157-BA93FD3A-40AD-43AE-AA49-C47ABA8AA910Q27330969-555C0B12-84C5-42DB-8178-E2F83788A329Q28240320-050B4B8B-CA64-42FA-A566-A4F40DD80C4FQ28483678-E9063D9C-9285-46A4-B304-282F4A84F9B7Q30529647-3D575001-9863-4ED9-AD32-D79E31ED0BD6Q34153953-6036B514-8459-46D8-A200-F83F56A3DF52Q34183137-415C8B4F-0BEA-430C-A5EE-3C3783A78B9CQ34601524-CAE20364-511F-4323-9B22-8B0BEBCB1DC6Q35596709-42293A38-51D2-4E7C-A531-5D12B60E058BQ35636354-E3D51D34-9C7A-4550-98AA-CABD262A4938Q35686793-E41DF268-AEE9-401C-8EE8-6A5E813A6339Q36254286-43DE9BCE-1261-4768-A3CA-8A48904D6904Q36600856-3A7CD685-01DB-4D06-AD29-309CA6BDBA04Q37131507-A417EAC2-1ED3-4D75-B19E-33398E466484Q37547699-C8D34515-8D04-4F24-9D79-60A85943EF3EQ37931912-03FF6E26-1275-4AD5-81CF-C723C5963FF8Q37945434-676EAC4B-608A-4782-BD08-888B5E997A83Q37947517-EDC41FD0-8503-42CE-9323-461ACE044E6CQ37950950-AEA1FC4C-285E-4CED-8E44-EE55BBFCEC20Q37959029-54097B8B-2943-424A-80AB-889BF3781176Q37964983-4A235148-E33F-42E1-889B-9A83F393DFA0Q38027106-2A650D9A-B389-463A-93CC-7FAC8664F310Q38040206-51751988-C319-4C59-AD7B-D0257C6F8662Q38042625-6C1CB469-4247-4D43-B12A-6915441F13C5Q38042792-0B9176F4-74DB-414D-A9F3-782FFDCDA594Q38149683-C2AD3DA1-A891-4D5E-975F-CBBC9A46E30BQ38700082-695311D8-3E75-4AB9-AD5F-6349CF34A162Q38743894-C90A077E-5944-40FB-AF4D-5ABA20CBC763Q39203764-C4E15A3C-45B4-49FD-BED7-E8366B282CABQ39485853-BFD2FC46-6C68-46EA-954E-917444763580Q41573786-58C8D345-39A3-4081-8C38-7226696C594AQ42605371-FC36E5F1-B6D3-4F25-9AF0-44E213EFB4A6Q47970651-49745F79-7A63-4F82-BC55-0336B8C267FCQ48326443-A77AC575-CDD0-422D-931A-F7709235821CQ48701650-481DD7CE-7FBB-47C4-84E1-915A616DA9DEQ50509476-4D911CB3-6AF3-41BF-BB11-B30749BD4E8EQ53295638-F134C553-DD05-4758-B9A7-BC8C0BA9216AQ59072379-6443ED33-53A8-4341-A36D-6FF7F49A4EC8
P2860
Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiomyocyte differentiation ...... use as cardiac disease models.
@en
Cardiomyocyte differentiation ...... use as cardiac disease models.
@nl
type
label
Cardiomyocyte differentiation ...... use as cardiac disease models.
@en
Cardiomyocyte differentiation ...... use as cardiac disease models.
@nl
prefLabel
Cardiomyocyte differentiation ...... use as cardiac disease models.
@en
Cardiomyocyte differentiation ...... use as cardiac disease models.
@nl
P2093
P2860
P356
P1433
P1476
Cardiomyocyte differentiation ...... use as cardiac disease models.
@en
P2093
Cheryl Dambrot
Douwe Atsma
Robert Passier
P2860
P356
10.1042/BJ20101707
P407
P577
2011-02-01T00:00:00Z